| Product Code: ETC11423118 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Advanced Therapy Medicinal Products CDMO Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 India Advanced Therapy Medicinal Products CDMO Market - Industry Life Cycle |
3.4 India Advanced Therapy Medicinal Products CDMO Market - Porter's Five Forces |
3.5 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.7 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Advanced Therapy Medicinal Products CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India, leading to higher demand for advanced therapy medicinal products. |
4.2.2 Growth in investments and collaborations in the biopharmaceutical sector in India. |
4.2.3 Favorable government regulations and policies supporting the development and commercialization of advanced therapy medicinal products. |
4.3 Market Restraints |
4.3.1 Limited awareness and understanding of advanced therapy medicinal products among healthcare professionals and patients in India. |
4.3.2 High initial capital investment required for setting up advanced therapy medicinal products manufacturing facilities. |
4.3.3 Challenges in scaling up production and ensuring consistent quality in advanced therapy medicinal products manufacturing. |
5 India Advanced Therapy Medicinal Products CDMO Market Trends |
6 India Advanced Therapy Medicinal Products CDMO Market, By Types |
6.1 India Advanced Therapy Medicinal Products CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.4 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.5 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Tissue-Engineered Products, 2021 - 2031F |
6.2 India Advanced Therapy Medicinal Products CDMO Market, By Service |
6.2.1 Overview and Analysis |
6.2.2 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.2.3 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Research & Development, 2021 - 2031F |
6.2.4 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 India Advanced Therapy Medicinal Products CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
6.3.4 India Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
7 India Advanced Therapy Medicinal Products CDMO Market Import-Export Trade Statistics |
7.1 India Advanced Therapy Medicinal Products CDMO Market Export to Major Countries |
7.2 India Advanced Therapy Medicinal Products CDMO Market Imports from Major Countries |
8 India Advanced Therapy Medicinal Products CDMO Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on advanced therapy medicinal products in India. |
8.2 Rate of adoption of advanced therapy medicinal products by healthcare facilities in India. |
8.3 Number of new partnerships and collaborations between Indian and international biopharmaceutical companies for advanced therapy medicinal products development. |
8.4 Percentage increase in the number of skilled professionals trained in advanced therapy medicinal products manufacturing processes in India. |
9 India Advanced Therapy Medicinal Products CDMO Market - Opportunity Assessment |
9.1 India Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.3 India Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Advanced Therapy Medicinal Products CDMO Market - Competitive Landscape |
10.1 India Advanced Therapy Medicinal Products CDMO Market Revenue Share, By Companies, 2024 |
10.2 India Advanced Therapy Medicinal Products CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here